Luminex Q4 Revenues Grow 5 Percent on Assay Sales

Feb 02, 2015

|

NEW YORK (GenomeWeb) – Luminex said after the close of the market today that its fourth quarter revenues increased 5 percent year over year driven primarily by strong assay sales.

For the fourth quarter ended Dec. 31, 2014, Luminex reported $58.1 million in revenues compared to $55.2 million in the year-ago period and just below analysts' consensus estimate of $58.3 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

New Nature EIC Talks Transparency

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic Genealogy for Another Arrest

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

This Week in PLOS

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Working With Others

Wired reports that 23andMe is trying to bolster its outside collaborations.

Main menu